164 related articles for article (PubMed ID: 18200504)
1. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I; Garcia-Munoz R; Martinez-Pasamar S; Inoges S; Lopez-Diaz de Cerio A; Palacios R; Sepulcre J; Moreno B; Gonzalez Z; Fernandez-Diez B; Melero I; Bendandi M; Villoslada P
Eur J Immunol; 2008 Feb; 38(2):576-86. PubMed ID: 18200504
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
4. Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.
Yaldizli O; Kumar M; Vago S; Kreuzfelder E; Limmroth V; Putzki N
Eur Neurol; 2009; 62(6):321-6. PubMed ID: 19752558
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
Valencia-Pacheco G; Layseca-Espinosa E; Niño-Moreno P; Portales-Pérez DP; Baranda L; Rosenstein Y; Abud-Mendoza C; González-Amaro R
Scand J Rheumatol; 2006; 35(5):368-78. PubMed ID: 17062437
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
Chiarini M; Serana F; Zanotti C; Capra R; Rasia S; Rottoli M; Rovaris M; Caputo D; Cavaletti G; Frigo M; Frigeni B; Clerici R; Rezzonico M; Caimi L; Imberti L
Mult Scler; 2012 Jun; 18(6):788-98. PubMed ID: 22086901
[TBL] [Abstract][Full Text] [Related]
9. Helminth infections associated with multiple sclerosis induce regulatory B cells.
Correale J; Farez M; Razzitte G
Ann Neurol; 2008 Aug; 64(2):187-99. PubMed ID: 18655096
[TBL] [Abstract][Full Text] [Related]
10. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms.
Correale J; Farez M
J Immunol; 2009 Nov; 183(9):5999-6012. PubMed ID: 19812189
[TBL] [Abstract][Full Text] [Related]
11. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
12. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
Putzki N; Kumar M; Kreuzfelder E; Grosse-Wilde H; Diener HC; Limmroth V
Eur Neurol; 2009; 61(1):27-32. PubMed ID: 18948697
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
[TBL] [Abstract][Full Text] [Related]
15. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
16. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases.
Brun V; Bastian H; Neveu V; Foussat A
Int Immunopharmacol; 2009 May; 9(5):609-13. PubMed ID: 19539556
[TBL] [Abstract][Full Text] [Related]
17. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
18. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.
Astier AL; Meiffren G; Freeman S; Hafler DA
J Clin Invest; 2006 Dec; 116(12):3252-7. PubMed ID: 17099776
[TBL] [Abstract][Full Text] [Related]
19. Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.
Fritzsching B; Korporal M; Haas J; Krammer PH; Suri-Payer E; Wildemann B
J Neurol Sci; 2006 Dec; 251(1-2):91-7. PubMed ID: 17092518
[TBL] [Abstract][Full Text] [Related]
20. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta.
Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A
Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]